March 12, 2010 (FinancialWire) — Cobalis Corp. (OTC: CLSC) said it has executed an exclusive international broker agreement covering sales of the company’s flagship anti-allergy product, PreHistin, with EXIM Intertrading Bancorp.

According to Cobalis, the agreement provides EXIM a four year exclusivity to represent and solicit purchase orders for PreHistin in most countries of the former Soviet Union, and throughout most countries of the former Yugoslavia.

As part of the terms of the agreement, EXIM has secured for Cobalis a bank-guaranteed purchase order for the sale of PreHistin to OC STROYPROEKT, a Moscow based pharmaceutical and healthcare product marketer.

Cobalis said that the terms of the purchase order call for delivery by Cobalis of the complete quantity ordered via the firm purchase order by January 31, 2011 with a total purchase price of $20 million.

The company added that the purchase order is irrevocably guaranteed on behalf of OC STROYPROEKT by SBERBANK, the largest bank in Russia, payable upon delivery of PreHistin over the next 11 months.

California-based Cobalis is an over the counter pharmaceutical and nutraceutical development company. Its flagship product, “PreHistin, is designed to mitigate overproduction of IgE levels, to restore normal response to seasonal and year-round indoor and outdoor allergens and reduce the likelihood of onset of allergy symptoms resulting from histamine release.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.